Gralnek, Ian M.
Hassan, Cesare
Dinis-Ribeiro, Mario
Article History
First Online: 13 May 2020
Competing interests
: I.M.G. has received lecture fees from Astra-Zeneca, Taro Pharma, Vifor Pharma and 3D Matrix. He is also a paid consultant for Boston Scientific, GI View, Motus GI and Symbionix and is a member of the medical advisory board of Motus GI. The remaining authors declare no competing interests.
Free to read: This content has been made available to all.